Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NuCana PLC NCNA

Healthcare Biotechnology
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NCNA)

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 25, 2024

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

GlobeNewswire November 11, 2024

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

GlobeNewswire September 25, 2024

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

GlobeNewswire September 14, 2024

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

GlobeNewswire August 29, 2024

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire August 15, 2024

NuCana to Present at the Jefferies Global Healthcare Conference

GlobeNewswire May 30, 2024

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

GlobeNewswire May 21, 2024

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire May 16, 2024
View More News ››

Opinion & Analysis (NDAQ:NCNA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NCNA)

NuCana Announces Encouraging Initial Data from Phase 1b/2 Mo

Just In: $NCNA NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or...
whytestocks - November 11, 2024

NuCana Announces Grant of Composition-of-Matter Patent for N

BREAKING NEWS: $NCNA NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738&#xA0;in the United StatesEDINBURGH, United...
whytestocks - September 25, 2024

NCNA Upgrade out with 150$ Price Target Low Float 4$

NCNA Upgrade out with 150$ price target Currently 4$ Low Float Phase 2 Data due soon https://www.investing.com/news/company-news/nucana...
10QKing - August 19, 2024

US Companies Moving the Markets, Morning edition <br>Tue, Ap

Just In: $NCNA US Companies Moving the Markets, Morning edition Tue, Apr 16, 2024 as of 10.00 am ETA look at the top 10 most actives in...
whytestocks - April 16, 2024

NuCana Announces Completion of ADS Ratio Change

NEWS: $NCNA NuCana Announces Completion of ADS Ratio ChangeEDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc...
whytestocks - April 16, 2024

NCNA.....day 2 of volume and Price Action

On watch....no News Release No positon
Iseneschal - March 13, 2024
View more Bullboard ››

LQWD Technologies Corp.

LQWD Technologies Corp.

LQWD Technologies Corp. is a Canada-based Bitcoin lightning network company. The Company is the provider of enterprise-grade ...
View More »